Tick-Borne Disease Working Group
October 24-25, 2022, TBDWG Meeting (online)
Back to Tick-Borne Disease Working Group Meetings
October 24, 2022 - October 25, 2022
Archived Webcast, Day 1, Part 1
Archived Webcast, Day 1, Part 2
Archived Webcast, Day 2, Part 1
Archived Webcast, Day 2, Part 2
Archived Webcast, Day 2, Part 3
Agenda
Agenda is Tentative and Subject to Change
Day 1 – October 24, 2022
| Time | Agenda Item | Speaker |
|---|---|---|
| 12:00 pm – 12:03 pm | Welcome from the Working Group Roll Call | Jim Berger, DFO |
| 12:03 pm – 12:07 pm | Recap of Meeting #23 Review of Meeting #24 Goals and Agenda | Holiday Goodreau, Co-Chair Linden Hu, Co-Chair |
| 12:07 pm – 12:10 pm | Overview of the Working Group’s Mission, Vision Statement, Values | Jim Berger, DFO |
| 12:10 pm – 12:55 pm | Discussion and Vote on the Disease Prevention and Treatment Chapter | Working Group |
| 12:55 pm – 1:40 pm | Discussion and Vote on the Access to Care Chapter | Working Group |
| 1:40 pm – 1:50 pm | Break | |
| 1:50 pm – 2:20 pm | Federal Inventory Update | Meghan Walsh, RLA |
| 2:20 pm – 3:00 pm | Unresolved Issues | Working Group |
| 3:00 pm | Adjourn | Jim Berger, DFO |
Day 2 – October 25, 2022
| Time | Agenda Item | Speaker |
|---|---|---|
| 10:00 am – 10:05 am | Welcome from the Working Group
| Jim Berger, DFO Holiday Goodreau, Co-Chair Linden Hu, Co-Chair |
| 10:05 am – 10:35 am | Public Comments | Working Group |
| 10:35 am – 11:15 am | Public Comment Chapter review and vote | Working Group |
| 11:15 am – 12:00 pm | Discussion on implementation recommendation rationale | Working Group |
| 12:00 pm – 12:30 pm | Lunch | |
| 12:30 pm – 1:45 pm | Executive Summary, Introduction, and Conclusion Chapters – final review and vote | Working Group |
| 1:45 pm – 2:45 pm | Unresolved issues | Working Group |
| 2:45 pm – 3:15 pm | Final Vote on Report to Congress | Working Group |
| 3:15 pm – 3:30 pm | Review of Meeting #21 Next Steps Next Meeting of the Working Group | Holiday Goodreau, Co-Chair Linden Hu, Co-Chair |
| 3:30 pm | Adjourn | Jim Berger, DFO |
Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed December 13, 2022